![]() |
Breast cancer drug development work moves forward with support from STTR grant
Triple negative breast cancer is an aggressive subtype of breast cancer with worse survival outcomes than most.
More... |
| All times are GMT -7. The time now is 04:21 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021